|Articles|December 1, 2004

December 2004
Volume 10
Issue 12

Dr McMahon's Commentary in the October 2004 Issue

Author(s)Bradford Kirkman-Liff, DrPH

Articles in this issue

almost 22 years ago

Article

Prevalence of Comorbid Hypertension and Dyslipidemia and Associated Cardiovascular Disease

almost 22 years ago

Article

Health Plans' Coverage Determinations for Technology-based Interventions: The Case of Electrical Bone Growth Stimulation

almost 22 years ago

Article

Asthma Disease Management: Regression to the Mean or Better?

almost 22 years ago

Article

The Relationships Among Age, Chronic Conditions, and Healthcare Costs

almost 22 years ago

Article

Mental Health Disorders and Sexually Transmitted Diseases in a Privately Insured Population

almost 22 years ago

Article

The Relationship Between Organizational Systems and Clinical Quality in Diabetes Care

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Dr McMahon's Commentary in the October 2004 Issue

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD

Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD

Counseling Vitiligo Patients on Time to Repigmentation

5 August FDA Approvals Marked by Novelty, Pushback

60% of US Women Face Barriers to Postpartum, Mental Health Care